Valley Fever Awareness and Vaccine Development and Manufacturing Act of 2024
Latest Action
Referred to the House Committee on Energy and Commerce.
Official Summary
Official summary has not been imported yet.
GovScope Watchdog™
AI Government Intelligence™The Valley Fever Awareness and Vaccine Development and Manufacturing Act of 2024 is a House bill introduced in the 118th Congress aimed at addressing Valley Fever, a fungal disease. The bill focuses on increasing awareness of Valley Fever and promoting the development and manufacturing of vaccines to prevent the disease. The bill was referred to the House Committee on Energy and Commerce but ultimately failed or expired without further legislative action. No official summary or full text is available to provide detailed provisions or mechanisms.
This bill sought to enhance public health efforts related to Valley Fever through awareness and vaccine development but did not advance beyond committee referral and expired.
- The bill targets Valley Fever, a health concern caused by a fungal infection.
- It aims to promote awareness and support vaccine development and manufacturing.
- The bill was referred to the House Committee on Energy and Commerce but did not progress further.
['Individuals at risk of Valley Fever infection', 'Public health agencies involved in infectious disease control', 'Biotechnology and pharmaceutical companies engaged in vaccine research and manufacturing']
['Lack of detailed information on funding sources or budget impact', 'Unclear implementation mechanisms due to absence of full bill text', 'No information on oversight or enforcement provisions']
The bill was introduced in the House during the 118th Congress and referred to the House Committee on Energy and Commerce. It did not advance beyond this stage and is listed as failed or expired. The policy area is health, specifically infectious disease prevention. No further legislative actions or debates are recorded.
Hidden impact flags detected: 2
GovScope reviewed 2 policy-risk categories. Hover for a quick definition. Click detected flags for bill-specific details.
['Increased public awareness could lead to earlier diagnosis and treatment of Valley Fever.', 'Stimulating vaccine development may encourage innovation in fungal disease prevention.', 'Potential growth in related biotech sectors due to increased government focus.']
The absence of an official summary and full bill text limits comprehensive analysis. Transparency about funding, implementation, and oversight provisions is lacking, which are critical for evaluating the bill's feasibility and impact. The bill's failure to progress beyond committee referral suggests limited legislative momentum.
GovScope Intelligence Roadmap
Future bill intelligence will connect sponsors, committee referrals, related votes, campaign finance, disclosures, and stock trades into one legislative intelligence view.